Physician profile
Teodor C Pitea
NPI 1710193016
$11,220.20
in general payments reported to CMS, 2019-2025
25 companies · $2,557 in 2025
The $2,557 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $1,303 · 2021: $1,036 · 2022: $3,386 · 2023: $652 · 2024: $689 · 2025: $2,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,019 · Consulting Fee: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.50 |
| Consulting Fee | $880.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,494.88 | 2019-2025 | Wallflex Duodenal, General - Biliary Devices, General - Therapies |
| W. L. Gore & Associates, INC. | $1,955.00 | 2022 | |
| Conmed Corporation | $1,071.96 | 2019-2023 | Conmed Biliary, Conmed Generators |
| Abbvie INC. | $981.64 | 2019-2025 | |
| Olympus Medical Systems Corporation | $880.00 | 2025 | |
| Olympus America INC. | $527.23 | 2019-2025 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope, Hanarostent Esophagus Tts(Ccc) |
| Fujifilm Healthcare Americas Corporation | $519.69 | 2020-2025 | |
| Medtronic, INC. | $363.33 | 2021-2025 | Nexpowder |
| Creo Medical INC. | $343.44 | 2022-2023 | Speedboat |
| Enterra Medical, INC. | $202.07 | 2025 | |
| Ambu INC. | $139.13 | 2020-2021 | |
| Merit Medical Systems INC | $125.00 | 2020 | |
| Erbe USA INC | $120.56 | 2022 | |
| Pentax of America, INC. | $108.54 | 2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Omega Medical Imaging, LLC | $84.93 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $57.52 | 2025 | Zenpep |
| Shionogi INC | $40.01 | 2019 | |
| Lumendi LLC | $37.93 | 2020 | |
| Genzyme Corporation | $34.13 | 2024 | |
| Alcresta Therapeutics, INC. | $30.29 | 2025 | Relizorb |
| Amgen INC. | $28.22 | 2025 | Uplizna |
| Covidien LP | $23.10 | 2019 | |
| Pinnacle Biologics, INC | $22.97 | 2025 | Photofrin |
| Ardelyx, INC. | $15.06 | 2023 | Ibsrela |
| Merck Sharp & Dohme LLC | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teodor Pitea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.